Home / Petrochemicals / Tardive Dyskinesia Global Clinical Trials Review, H1, 2015

Tardive Dyskinesia Global Clinical Trials Review, H1, 2015

Published: Apr 2015 | No Of Pages: 65 | Published By: GlobalData

Tardive Dyskinesia Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Tardive Dyskinesia Global Clinical Trials Review, H1, 2015" provides data on the Tardive Dyskinesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tardive Dyskinesia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tardive Dyskinesia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Tardive Dyskinesia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Tardive Dyskinesia to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Tardive Dyskinesia to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Tardive Dyskinesia 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Tardive Dyskinesia Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Tardive Dyskinesia 31
Feb 03, 2015: Auspex Pharmaceuticals Completes Enrollment in a Pivotal Clinical Trial of SD-809 in Tardive Dyskinesia 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Neurocrine Biosciences, Inc. 32
Clinical Trial Overview of Neurocrine Biosciences, Inc. 32
Teva Pharmaceutical Industries Limited 33
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 33
UCB S.A. 34
Clinical Trial Overview of UCB S.A. 34
Synchroneuron Inc. 35
Clinical Trial Overview of Synchroneuron Inc. 35
Medicure Inc. 36
Clinical Trial Overview of Medicure Inc. 36
Clinical Trial Overview of Top Institutes / Government 37
Beersheva Mental Health Center 37
Clinical Trial Overview of Beersheva Mental Health Center 37
Beijing Huilongguan Hospital 38
Clinical Trial Overview of Beijing Huilongguan Hospital 38
Taoyuan Mental Hospital 39
Clinical Trial Overview of Taoyuan Mental Hospital 39
Baylor College of Medicine 40
Clinical Trial Overview of Baylor College of Medicine 40
Ben-Gurion University of the Negev 41
Clinical Trial Overview of Ben-Gurion University of the Negev 41
Centre for Addiction and Mental Health 42
Clinical Trial Overview of Centre for Addiction and Mental Health 42
Centre Hospitalier Universitaire, Amiens 43
Clinical Trial Overview of Centre Hospitalier Universitaire, Amiens 43
Herzog Hospital 44
Clinical Trial Overview of Herzog Hospital 44
Lawson Health Research Institute 45
Clinical Trial Overview of Lawson Health Research Institute 45
Parnassia Psycho Medical Centre 46
Clinical Trial Overview of Parnassia Psycho Medical Centre 46
Five Key Clinical Profiles 47
Appendix 63
Abbreviations 63
Definitions 63
Research Methodology 64
Secondary Research 64
About GlobalData 65
Contact Us 65
Disclaimer 65
Source 65

List of Tables
Tardive Dyskinesia Therapeutics, Global, Clinical Trials by Region, 2015* 7
Tardive Dyskinesia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Tardive Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Tardive Dyskinesia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Tardive Dyskinesia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Tardive Dyskinesia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Tardive Dyskinesia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Tardive Dyskinesia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 14
Tardive Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Tardive Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Tardive Dyskinesia to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 17
Tardive Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Tardive Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Tardive Dyskinesia Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Tardive Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Tardive Dyskinesia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Tardive Dyskinesia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Tardive Dyskinesia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24
Tardive Dyskinesia Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Tardive Dyskinesia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Tardive Dyskinesia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Tardive Dyskinesia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Tardive Dyskinesia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Tardive Dyskinesia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurocrine Biosciences, Inc., 2015* 32
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2015* 33
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2015* 34
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Synchroneuron Inc., 2015* 35
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medicure Inc., 2015* 36
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Beersheva Mental Health Center, 2015* 37
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Huilongguan Hospital, 2015* 38
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Taoyuan Mental Hospital, 2015* 39
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015* 40
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ben-Gurion University of the Negev, 2015* 41
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre for Addiction and Mental Health, 2015* 42
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire, Amiens, 2015* 43
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Herzog Hospital, 2015* 44
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2015* 45
Tardive Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Parnassia Psycho Medical Centre, 2015* 46

List of Figures
Tardive Dyskinesia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Tardive Dyskinesia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Tardive Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Tardive Dyskinesia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Tardive Dyskinesia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Tardive Dyskinesia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Tardive Dyskinesia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Tardive Dyskinesia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 14
Tardive Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Tardive Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Tardive Dyskinesia to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 17
Tardive Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Tardive Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Tardive Dyskinesia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Tardive Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Tardive Dyskinesia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Tardive Dyskinesia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Tardive Dyskinesia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Tardive Dyskinesia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Tardive Dyskinesia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Tardive Dyskinesia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Tardive Dyskinesia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 64

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +